跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
APO-ATOMOXETINE atomoxetine (as hydrochloride) 80 mg capsule blister - TGA Drug Approval Details
Approvals
/
TGA
/
APO-ATOMOXETINE atomoxetine (as hydrochloride) 80 mg capsule blister
Approved
STANDARD
APO-ATOMOXETINE atomoxetine (as hydrochloride) 80 mg capsule blister
Arrotex Pharmaceuticals Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
ad49ee40d9a06d20
Company
Arrotex Pharmaceuticals Pty Ltd
Type
Standard
Approval Details
Approval Id
ad49ee40d9a06d20
Product Name
APO-ATOMOXETINE atomoxetine (as hydrochloride) 80 mg capsule blister
Artg Id
290984
Artg Name
APO-ATOMOXETINE atomoxetine (as hydrochloride) 80 mg capsule blister
Sponsor
Arrotex Pharmaceuticals Pty Ltd
Company Detail Path
/organization/arrotex-pharmaceuticals-pty-ltd
Artg Date
2017-09-29
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/c3a3758625645f7b14cd6eb1bf381986.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/f9192ad0a2ba36970f8978784020dc8e.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
ad49ee40d9a06d20
Type
Standard
Back to TGA Approvals
